Engineered cells that sense and respond to interleukin-23 with neutralizing therapy for autoimmunity.

Garza GL, Danon SNL, Wuchter J, Morris AH

DOI: 10.64898/2026.10.12.758578
Published: 2026 Oct 14
Container: bioRxiv : the preprint server for biology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.10.12.758578,
  title = {Engineered cells that sense and respond to interleukin-23 with neutralizing therapy for autoimmunity.},
  author = {Garza GL and Danon SNL and Wuchter J and Morris AH},
  year = {2026},
  journal = {bioRxiv : the preprint server for biology},
  doi = {10.64898/2026.10.12.758578},
  url = {https://doi.org/10.64898/2026.10.12.758578}
}

RIS

TY  - JOUR
TI  - Engineered cells that sense and respond to interleukin-23 with neutralizing therapy for autoimmunity.
AU  - Garza GL
AU  - Danon SNL
AU  - Wuchter J
AU  - Morris AH
PY  - 2026
JO  - bioRxiv : the preprint server for biology
DO  - 10.64898/2026.10.12.758578
UR  - https://doi.org/10.64898/2026.10.12.758578
ER  -

APA

GL, G., SNL, D., J, W., & AH, M. (2026). Engineered cells that sense and respond to interleukin-23 with neutralizing therapy for autoimmunity.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.10.12.758578

Source records

pubmed · retrieved 2026-11-10T14:24:59.989Z
europe-pmc · retrieved 2026-11-10T14:25:00.000Z